Mitochondrial Dysfunction in Metabolic Disease
Journal: The Indonesian Biomedical Journal (Vol.4, No. 3)Publication Date: 2012-12-01
Authors : Anna Meiliana; Andi Wijaya;
Page : 119-28
Keywords : Mitochondrial biogenesis; Mitochondrial dysfunction; Reactive oxygen species (ROS); Metabolic diseases;
Abstract
BACKGROUND: Mitochondrial function and behavior are central to the physiology of humans and, consequently, "mitochondrial dysfunction" has been implicated in a wide range of disease. CONTENT: Mitochondrial ROS might attack various mitochondrial constituents, causing mitochondrial DNA mutations and oxidative damage to respiratory enzymes. A defect in mitochondrial respiratory enzymes would increase mitochondrial production of ROS, causing further mitochondrial damage and dysfunction. Mitochondrial dysfunction is associated with diseases, such as neurodegenerative disorders, cardiomyopathies, metabolic syndrome, obesity, and cancer. Pathways that improve mitochondrial function, attenuate mitochondrial oxidative stress, and regulate mitochondrial biogenesis have recently emerged as potential therapeutic targets. SUMMARY: Mitochondria perform diverse yet interconnected functions, produce ATP and many biosynthetic intermediates while also contribute to cellular stress responses such as autophagy and apoptosis. Mitochondria form a dynamic, interconnected network that is intimately integrated with other cellular compartments. It is therefore not suprising that mitochondrial dysfunction has emerged as a key factor in a myriad of diseases, including neurodegenerative, cancer, and metabolic disorders. Interventions that modulate processes involved in regulation of mitochondrial turnover, with calorie restriction and induction of mitochondrial biogenesis, are of particular interest.
Other Latest Articles
- GFAP and S100B Protein are Associated with Discharged NIHSS of Anterior Circulation Ischemic Stroke
- Association Between Plasma Beta-endorphin and WOMAC Score in Female Patients with Knee Osteoarthritis
- The Correlation between Lipoprotein-Associated Phospholipase A2 and Atherosclerosis (ox-LDL) in Centrally Obese Men
- Analysis of Ghrelin and Asymmetric Dimethylarginine (ADMA) as Endothelial Dysfunction Marker Among Obese Men
- 25(OH)D was Correlated with Increased Risk of Insulin Resistance, but Not Mediated by Adiponectin and hsCRP
Last modified: 2016-04-13 13:29:12